Market revenue in 2023 | USD 58.6 million |
Market revenue in 2030 | USD 92.5 million |
Growth rate | 6.7% (CAGR from 2023 to 2030) |
Largest segment | 100 to 150 mm |
Fastest growing segment | Smaller Than 100 mm |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | 100 to 150 mm, Larger Than 150 mm, Smaller Than 100 mm |
Key market players worldwide | Smiths Group PLC, Integra LifeSciences, Cook Medical, CooperSurgical, Medline Industries, Rocket Pharmaceuticals Inc, Becton Dickinson & Co, BPB Medica, Laboratoire CCD |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to amniocentesis needle market will help companies and investors design strategic landscapes.
100 to 150 mm was the largest segment with a revenue share of 51.02% in 2023. Horizon Databook has segmented the North America amniocentesis needle market based on 100 to 150 mm, larger than 150 mm, smaller than 100 mm covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America amniocentesis needle market , including forecasts for subscribers. This continent databook contains high-level insights into North America amniocentesis needle market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account